Trials / Terminated
TerminatedNCT01791127
Safety and Performance Study of the Siello S Pacing Lead
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,758 (actual)
- Sponsor
- Biotronik, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of the SIELLO study is to demonstrate the safety and effectiveness of the BIOTRONIK Siello S pacing lead.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | market-released BIOTRONIK pacemaker system including one or two Siello S leads. |
Timeline
- Start date
- 2013-03-13
- Primary completion
- 2019-04-17
- Completion
- 2019-04-17
- First posted
- 2013-02-13
- Last updated
- 2020-06-01
- Results posted
- 2020-04-22
Locations
53 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01791127. Inclusion in this directory is not an endorsement.